- $1.20tn
- $1.24tn
- $65.18bn
Lilly's next-gen drug outshines Ozempic on weight loss, blood sugar control in trial
Biogen beats third-quarter results on strength in rare disease drugs
Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit
Brief: Patrik Jonsson To Retire After 36 Years Ilya Yuffa Named President, Lilly Global Markets
Brief: Counsel Health Launches Weight Management Program,Working With Lillydirect, Eli Lilly And Co's Direct To Consumer Digital Pharmacy
Hengrui Pharma reports 88.9% rise in 2026 third-quarter profit on licensing deals
Indian drugmaker Cipla misses profit view on US weakness, shares slip (updated)
US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk (updated)
Corrected: UPDATE 2-US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk
US judge lets Eli Lilly continue ads for weight-loss drugs, rules against Novo Nordisk
US STOCKS ON THE MOVE-Talen Energy, Nvidia, AMD
Brief: Eli Lilly Declares Q4 2026 Dividend Of $1.73 Per Share
U.S. STOCKS ON THE MOVE-Roper, Corcept, Moderna
U.S. STOCKS ON THE MOVE-Meta, Tesla, Verizon
Bernstein boosts Eli Lilly PT on international Mounjaro strength
RCS - EZRA - EZRA Launches Loop to Give Every Manager a Coach
Graphic: Take Five: AI trade meets the Fed
Brief: Lilly Presents First Clinical Data In Platinum-Sensitive Ovarian Cancer For Its Investigational, Next-Generation, Frα-Targeting ADC
CVS is trying out pharmacists in chronic health management